Findings from the current study demonstrate that over half of chronic HF patients in the DIG trial had severe and more advanced disease as evidenced by the presence of NYHA III–IV symptoms, LVEF <25%, ...
Senior researcher Dr Ali Ahmed (University of Alabama, Birmingham) told heartwire that the differing conclusions are the result of two different methodologies used to analyze the data. He said their ...
When a 24-year-old woman took a dietary supplement called "raiz de tejocote," she encountered some dangerous and unpleasant ...
MADRID, Spain—Adding digitoxin, a cardiac glycoside, to contemporary guideline-directed medical therapy (GDMT) improves clinical outcomes in patients who have heart failure with reduced ejection ...
Wearable device data could predict New York Heart Association functional class similarly to clinical measures and six-minute walk test. HealthDay News — For patients with atrial fibrillation, digoxin ...
Gemtesa is used to treat urinary urgency, frequency, and incontinence caused by an overactive bladder in adults. This includes certain males with benign prostatic hyperplasia (BPH). Digoxin (Lanoxin) ...
The NHS (National Health Service) urges anyone taking digoxin, a common heart medication, to watch for key side effects-and report them fast. Although this medication is used by patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results